1 completed, 1 recruiting, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Differentiated Thyroid Carcinoma: new trials by email Literature Review of Differentiated Thyroid Carcinoma trials Research Report on Differentiated Thyroid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer ST-1898 tablets - Differentiated Thyroid Carcinoma | Phase 2 | Recruiting | Beijing Scitech-Mq Pharmaceuticals Limited | 60 | 2023-11-15 | 2026-11-05 |
| Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma Apatinib Mesylate - Differentiated Thyroid Carcinoma | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 20 | 2017-03-22 | 2017-05-30 |
| Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer Lithium Carbonate, Placebo - Thyroid Cancer, Differentiated Thyroid Carcinoma | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 34 | 2005-11-01 | 2013-02-04 |
Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Thyroid Diseases (1)
3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid (1) · Lithium Carbonate (1) · apatinib (1)
Beijing Scitech-Mq Pharmaceuticals Limited (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (2) · United States (1)
Ming Gao, MD (1) · Monica C Skarulis, M.D. (1) · Yansong Lin, Ph D (1)